Detalhe da pesquisa
1.
Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.
Breast Cancer Res Treat
; 176(1): 27-36, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997625
2.
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 175(3): 605-615, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30868392
3.
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.
Cancer Treat Rev
; 62: 18-28, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154022
4.
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.
Oncoimmunology
; 7(8): e1465166, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221063
5.
CDK4/6 inhibition in early and metastatic breast cancer: A review.
Cancer Treat Rev
; 60: 130-138, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961554